Search

Author/Creator Elsayed, Y.

1. DISCOVERY OF A NOVEL, POTENTIAL FIRST‐IN‐CLASS MALT1 PROTEASE INHIBITOR FOR THE TREATMENT OF B CELL LYMPHOMAS. (12th June 2019)

Authors:
Philippar, U.; Lu, T.; Vloemans, N.; Bekkers, M.; van Nuffel, L.; Gaudiano, M.; Wnuk‐Lipinska, K.; Van Der Leede, B.; Amssoms, K.; Kimpe, K.; Medaer, B.; Greway, T.; Abraham, Y.; Cummings, M.; Trella, E.; Vanhoof, G.; Sun, W.; Thuring, J.; Connolly, P.; Linders, J.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome. (1st July 2016)

Authors:
Child, F.; Ortiz‐Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; Weichenthal, M.; Alves, R.; Quaglino, P.; Beylot‐Barry, M.; Cowan, R.; Geskin, L.J.; Pérez‐Ferriols, A.; Hellemans, P.; Elsayed, Y.; Phelps, C.; Forslund, A.; Kamida, M.; Zinzani, P.L.
Journal:
British journal of dermatology
Issue:
Volume 175:Number 1(2016)
Page Start:
80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome. (2nd June 2016)

Authors:
Child, F.; Ortiz‐Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; Weichenthal, M.; Alves, R.; Quaglino, P.; Beylot‐Barry, M.; Cowan, R.; Geskin, L.J.; Pérez‐Ferriols, A.; Hellemans, P.; Elsayed, Y.; Phelps, C.; Forslund, A.; Kamida, M.; Zinzani, P.L.
Journal:
British journal of dermatology
Issue:
Volume 175:Number 1(2016)
Page Start:
80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome3. (2nd June 2016)

Authors:
Child, F.; Ortiz‐Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; Weichenthal, M.; Alves, R.; Quaglino, P.; Beylot‐Barry, M.; Cowan, R.; Geskin, L.J.; Pérez‐Ferriols, A.; Hellemans, P.; Elsayed, Y.; Phelps, C.; Forslund, A.; Kamida, M.; Zinzani, P.L.
Journal:
British journal of dermatology
Issue:
Volume 175:Number 1(2016)
Page Start:
80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Born into an isolating world: family-centred care for babies born to mothers with COVID-19. (February 2023)

Authors:
Dowse, G.; Perkins, E.J.; Stein, H.M.; Chidini, G.; Danhaive, O.; Elsayed, Y.N.; Carvalho, W.B.; AlNaqeeb, N.; Rooze, S.; Cetinkaya, M.; Vetter-Laracy, S.; Pilar-Orive, F.J.; Torpiano, P.; Gonçalves Ferri, W.A.; Buonsenso, D.; Rogdo, B.; Medina, A.; Polito, A.; Brouwer, C.N.M.; Kneyber, M.C.J.
Journal:
EClinicalMedicine
Issue:
Volume 56(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗